3-4 Apr 2023 Marseille (France)

Program

‹ Tuesday, April 4, 2023
09:00
10:00
11:00
12:00
13:00
14:00
15:00
16:00
17:00
›9:00 (1h35)
Therapies
Atsuo Fukuda, Chairman
› Auditorium Hexagone
›9:00 (35min)
Putative therapies
Laura Cancedda, Institute of Technology, Genoa, Italy
›9:35 (30min)
KCC2 enhancers in mesial temporal lobe epilepsy
Jean christophe Poncer, Institut de Fer à Moulin, Paris , France
›10:05 (30min)
Predicting and treating Autism Spectrum disorders
Yehezkel Ben-Ari, Neurochlore @Iben, Marseille, France
›10:35 (55min)
Coffee break & Poster session II
› Exhibition hall Hexagone
›12:00 (1h)
Lunch
› Inmed cafeteria
›14:30 (35min)
Search for new SLC12A5 cases, EPI25
Gaetan Lesca, CHU Lyon
› Inmed Confrence room
›15:05 (35min)
Phosphorylation, structure of KCC2
Anna-Maria Hartman, Oldenburg University, Germany
› Inmed Confrence room
›15:40 (15min)
Coffee break
› Inmed cafeteria
›15:55 (20min)
Treating refractory neonatal seizures with KCC2 potentiator compounds
Shilpa Kadam, Axonis, Boston, USA
› Inmed Confrence room
›16:15 (35min)
The use of small molecule direct activators of KCC2 to arrest refractory seizures
Stephen J. Moss, Tufts University, Boston, USA
› Inmed Confrence room
›16:50 (15min)
Round table – conclusions
Igor Medina, INMED Marseille & Gaetan Lesca, CHU Lyon
› Inmed Confrence room
Session
Speech
Logistics
Break
Tour
Online user: 1 Privacy
Loading...